Ocular Therapeutix Inc OCULProduct Pipeline Analysis, 2017 Update, Market Trends, Market Growth: Ken Research
Ocular Therapeutix Inc (OCUL)-Product Pipeline Analysis, 2017 Update

Ocular Therapeutix Inc (OCUL)-Product Pipeline Analysis, 2017 Update


  • Products Id :- GDME225416PD
  • |
  • Pages: 33
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Summary

Ocular Therapeutix Inc (Ocular), formerly I-Therapeutix Inc is a biopharmaceutical company that discovers, develops, manufactures and commercializes therapies for diseases using hydrogel platform technology. The company's products include DEXTENZA, sustained release travoprost and posterior segment injections. Its hydrogel technology uses polyethylene glycol to create ophthalmic sustained drug delivery systems. Ocular's hydrogel provides containment, localization and protection from inflammatory response, and a material for sustained delivery of drugs to the eye. The company also provides ReSure Sealant, a ocular sealant proven in clinical trial to be safe in sealing clear corneal incisions following cataract surgery. Its products are used for the treatment of glaucoma and ocular hypertension, post-operative inflammation, allergic conjunctivitis, dry eye and retinal diseases. Ocular is headquartered in Bedford, Massachusetts, the US.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

The report analyzes all pipeline products in development for the company Ocular Therapeutix Inc

The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

The report provides detailed description of products in development, technical specification and functions

The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

To formulate effective Research & Development strategies

Develop market-entry and market expansion strategies

Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc

Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 3

Ocular Therapeutix Inc Company Overview 4

Ocular Therapeutix Inc Company Snapshot 4

Ocular Therapeutix Inc Pipeline Products and Ongoing Clinical Trials Overview 4

Ocular Therapeutix Inc-Pipeline Analysis Overview 7

Ocular Therapeutix Inc-Key Facts 7

Ocular Therapeutix Inc-Major Products and Services 8

Ocular Therapeutix Inc Pipeline Products by Development Stage 9

Ocular Therapeutix Inc Ongoing Clinical Trials by Trial Status 11

Ocular Therapeutix Inc Pipeline Products Overview 13

DEXTENZA 13

DEXTENZA Product Overview 13

Injectable Hydrogel Slurry-anti-VEGF 14

Injectable Hydrogel Slurry-anti-VEGF Product Overview 14

Moxifloxacin Punctum Plug 15

Moxifloxacin Punctum Plug Product Overview 15

OTX-TP 16

OTX-TP Product Overview 16

OTX-TP Clinical Trial 17

Ocular Therapeutix Inc-Key Competitors 18

Ocular Therapeutix Inc-Key Employees 19

Ocular Therapeutix Inc-Locations And Subsidiaries 20

Head Office 20

Other Locations & Subsidiaries 20

Recent Developments 21

Ocular Therapeutix Inc, Recent Developments 21

Jun 26, 2017: Ocular Therapeutix Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) 21

Jun 22, 2017: Ocular Therapeutix Announces Executive Transition Plans 21

May 11, 2017: Ocular Therapeutix Presented Phase 3 Data for DEXTENZA at the Association for Research in Vision and Ophthalmology Annual Meeting 21

May 05, 2017: Ocular Therapeutix Reports First Quarter 2017 Financial Results 23

May 02, 2017: Ocular Therapeutix Announces Presentation on ReSure Sealant at the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting 24

May 02, 2017: Ocular Therapeutix to Present Data on OTX-TP (travoprost insert) at the Association for Research in Vision and Ophthalmology Annual Meeting 25

May 02, 2017: Ocular Therapeutix Announces Data on DEXTENZA at the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting 25

Apr 06, 2017: Ocular Therapeutix Appoints George Migausky as Interim Chief Financial Officer 26

Mar 15, 2017: New Publication Describes Positive Patient Experience in Study of Ocular Therapeutix' DEXTENZA Following Cataract Surgery 26

Mar 10, 2017: Ocular Therapeutix Reports Fourth Quarter and Full Year 2016 Financial Results 27

Appendix 30

Methodology 30

About GlobalData 32

Contact Us 32

Disclaimer 32

List of Figures

Ocular Therapeutix Inc Pipeline Products by Equipment Type 5

Ocular Therapeutix Inc Pipeline Products by Development Stage 9

Ocular Therapeutix Inc Ongoing Clinical Trials by Trial Status 11

List of Tables

Ocular Therapeutix Inc Pipeline Products and Ongoing Clinical Trials Overview 4

Ocular Therapeutix Inc Pipeline Products by Equipment Type 5

Ocular Therapeutix Inc Pipeline Products by Indication 6

Ocular Therapeutix Inc Ongoing Clinical Trials by Trial Status 6

Ocular Therapeutix Inc, Key Facts 7

Ocular Therapeutix Inc, Major Products and Services 8

Ocular Therapeutix Inc Number of Pipeline Products by Development Stage 9

Ocular Therapeutix Inc Pipeline Products Summary by Development Stage 10

Ocular Therapeutix Inc Ongoing Clinical Trials by Trial Status 11

Ocular Therapeutix Inc Ongoing Clinical Trials Summary 12

DEXTENZA-Product Status 13

DEXTENZA-Product Description 13

Injectable Hydrogel Slurry-anti-VEGF-Product Status 14

Injectable Hydrogel Slurry-anti-VEGF-Product Description 14

Moxifloxacin Punctum Plug-Product Status 15

Moxifloxacin Punctum Plug-Product Description 15

OTX-TP-Product Status 16

OTX-TP-Product Description 16

OTX-TP-Non-significant Risk Feasibility Study to Assess Retention and Replacement of the OTX Punctum Plug 17

Ocular Therapeutix Inc, Key Employees 19

Ocular Therapeutix Inc, Other Locations 20

Glossary 31

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

Ocular Therapeutix Inc, Product, Pipeline, Product Pipeline, Key Pipeline, Products by Equipment Type, Equipment Type, Therapy Area, Products by Therapy Area, Development Stage, Products by Development Stage, Milestone, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies

select a license

Single User License
USD 750 INR 50588
Site License
USD 1500 INR 101175
Corporate User License
USD 2250 INR 151763

NEWSLETTER BY CATEGORY




Testimonials

An excellent provider. Thorough, precise and outstanding insight. They drill down to what we need and their reports are effective at integrating text with supporting graphics and charts. Their reports are a great resource to go back too. ...

Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process....

Well structured, the insights they shared with us were very helpful and reliable. Their timely assistance make their services invaluable to us. I would highly recommend them and would definitely use them again in the future if needed...

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...



Ken Research, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com